{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T01:19:40Z","timestamp":1787793580114,"version":"build-2784847793"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":71,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"DOI":"10.1186\/s12887-026-07114-9","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T01:34:57Z","timestamp":1781660097000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Procalcitonin levels as a predictor of antibiotic treatment in pediatric diabetic ketoacidosis"],"prefix":"10.1186","volume":"26","author":[{"given":"Katie D.","family":"Dolak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Davila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perrin C.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"7114_CR1","doi-asserted-by":"publisher","unstructured":"Alsabri M, Rath S, Okaruefe CO et al. Diabetic Ketoacidosis in Pediatric Emergency Medicine: Risk Factors, Myths, and Evidence-Based Management of Complications. Curr Emerg Hosp Me R. 2025;13(1) (In English). ARTN 6. https:\/\/doi.org\/10.1007\/s40138-025-00311-3.","DOI":"10.1007\/s40138-025-00311-3"},{"issue":"4","key":"7114_CR2","doi-asserted-by":"publisher","first-page":"OC42","DOI":"10.7860\/JCDR\/2017\/25347.9760","volume":"11","author":"MG Mahesh","year":"2017","unstructured":"Mahesh MG, Shivaswamy RP, Chandra BS, Syed S. The Study of Different Clinical Pattern of Diabetic Ketoacidosis and Common Precipitating Events and Independent Mortality Factors. J Clin Diagn Res. 2017;11(4):OC42\u20136. https:\/\/doi.org\/10.7860\/JCDR\/2017\/25347.9760.","journal-title":"J Clin Diagn Res"},{"issue":"4","key":"7114_CR3","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1053\/ajem.2001.24473","volume":"19","author":"RG Flood","year":"2001","unstructured":"Flood RG, Chiang VW. Rate and prediction of infection in children with diabetic ketoacidosis. Am J Emerg Med. 2001;19(4):270\u20133. https:\/\/doi.org\/10.1053\/ajem.2001.24473.","journal-title":"Am J Emerg Med"},{"issue":"7","key":"7114_CR4","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.2337\/dc14-2820","volume":"38","author":"DJ Magliano","year":"2015","unstructured":"Magliano DJ, Harding JL, Cohen K, Huxley RR, Davis WA, Shaw JE. Excess Risk of Dying From Infectious Causes in Those With Type 1 and Type 2 Diabetes. Diabetes Care. 2015;38(7):1274\u201380. https:\/\/doi.org\/10.2337\/dc14-2820.","journal-title":"Diabetes Care"},{"issue":"8","key":"7114_CR5","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s001250100592","volume":"44","author":"CA Gogos","year":"2001","unstructured":"Gogos CA, Giali S, Paliogianni F, Dimitracopoulos G, Bassaris HP, Vagenakis AG. Interleukin-6 and C-reactive protein as early markers of sepsis in patients with diabetic ketoacidosis or hyperosmosis. Diabetologia. 2001;44(8):1011\u20134. https:\/\/doi.org\/10.1007\/s001250100592.","journal-title":"Diabetologia"},{"key":"7114_CR6","doi-asserted-by":"publisher","unstructured":"Vincent JL, Van Nuffelen M, Lelubre C. Host response biomarkers in sepsis: the role of procalcitonin. Methods Mol Biol. 2015;1237:213-224. https:\/\/doi.org\/10.1007\/978-1-4939-1776-1_16.","DOI":"10.1007\/978-1-4939-1776-1_16"},{"issue":"11","key":"7114_CR7","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1080\/14787210.2017.1400907","volume":"15","author":"G Trippella","year":"2017","unstructured":"Trippella G, Galli L, De Martino M, Lisi C, Chiappini E. Procalcitonin performance in detecting serious and invasive bacterial infections in children with fever without apparent source: a systematic review and meta-analysis. Expert Rev Anti Infect Ther. 2017;15(11):1041\u201357. https:\/\/doi.org\/10.1080\/14787210.2017.1400907.","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"3","key":"7114_CR8","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1542\/hpeds.2023-007318","volume":"14","author":"R Beaumont","year":"2024","unstructured":"Beaumont R, Tang K, Gwee A. The Sensitivity and Specificity of Procalcitonin in Diagnosing Bacterial Sepsis in Neonates. Hosp Pediatr. 2024;14(3):199\u2013208. https:\/\/doi.org\/10.1542\/hpeds.2023-007318. (In English).","journal-title":"Hosp Pediatr"},{"issue":"1","key":"7114_CR9","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13613-020-00676-6","volume":"10","author":"F Blanchard","year":"2020","unstructured":"Blanchard F, Charbit J, Van der Meersch G, et al. Early sepsis markers in patients admitted to intensive care unit with moderate-to-severe diabetic ketoacidosis. Ann Intensive Care. 2020;10(1):58. https:\/\/doi.org\/10.1186\/s13613-020-00676-6.","journal-title":"Ann Intensive Care"},{"key":"7114_CR10","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.2147\/DMSO.S371437","volume":"15","author":"B Huang","year":"2022","unstructured":"Huang B, Yang S, Ye S. Systemic Infection Predictive Value of Procalcitonin to Lactic Acid Ratio in Diabetes Ketoacidosis Patients. Diabetes Metab Syndr Obes. 2022;15:2127\u201333. https:\/\/doi.org\/10.2147\/DMSO.S371437.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"6","key":"7114_CR11","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.diabet.2019.05.006","volume":"46","author":"T Anno","year":"2020","unstructured":"Anno T, Shigemoto R, Kawasaki F, et al. Marked elevation of plasma procalcitonin levels in patients with diabetic ketoacidosis: A possible useful diagnostic biomarker. Diabetes Metab. 2020;46(6):504\u20135. https:\/\/doi.org\/10.1016\/j.diabet.2019.05.006.","journal-title":"Diabetes Metab"},{"key":"7114_CR12","doi-asserted-by":"publisher","first-page":"111713","DOI":"10.1016\/j.diabres.2024.111713","volume":"212","author":"K Takahashi","year":"2024","unstructured":"Takahashi K, Uenishi N, Sanui M, et al. Epidemiology, microbiology, and diagnosis of infection in diabetic ketoacidosis and hyperosmolar hyperglycemic syndrome: A multicenter retrospective observational study. Diabetes Res Clin Pract. 2024;212:111713. https:\/\/doi.org\/10.1016\/j.diabres.2024.111713.","journal-title":"Diabetes Res Clin Pract"},{"issue":"8","key":"7114_CR13","doi-asserted-by":"publisher","first-page":"5299","DOI":"10.1007\/s10238-023-01169-z","volume":"23","author":"AK Pannu","year":"2023","unstructured":"Pannu AK, Kumar A, Kiran R, et al. Diagnostic utility of procalcitonin for bacterial infections in diabetic ketoacidosis. Clin Exp Med. 2023;23(8):5299\u2013306. https:\/\/doi.org\/10.1007\/s10238-023-01169-z.","journal-title":"Clin Exp Med"},{"issue":"9596","key":"7114_CR14","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453\u20137. https:\/\/doi.org\/10.1016\/S0140-6736(07)61602-X.","journal-title":"Lancet"},{"issue":"Supplement1","key":"7114_CR15","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.2337\/dc26-S002","volume":"49","author":"American Diabetes Association Professional Practice Committee for D. 2","year":"2026","unstructured":"American Diabetes Association Professional Practice Committee for D. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2026. Diabetes Care. 2026;49(Supplement1):S27\u201349. https:\/\/doi.org\/10.2337\/dc26-S002.","journal-title":"Diabetes Care"},{"issue":"8","key":"7114_CR16","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.2337\/dci24-0032","volume":"47","author":"GE Umpierrez","year":"2024","unstructured":"Umpierrez GE, Davis GM, ElSayed NA, et al. Hyperglycemic Crises in Adults With Diabetes: A Consensus Report. Diabetes Care. 2024;47(8):1257\u201375. https:\/\/doi.org\/10.2337\/dci24-0032.","journal-title":"Diabetes Care"},{"issue":"1","key":"7114_CR17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.14218\/JCTH.2018.00012","volume":"7","author":"R Dong","year":"2019","unstructured":"Dong R, Wan B, Lin S, et al. Procalcitonin and Liver Disease: A Literature Review. J Clin Transl Hepatol. 2019;7(1):51\u20135. https:\/\/doi.org\/10.14218\/JCTH.2018.00012.","journal-title":"J Clin Transl Hepatol"},{"issue":"4","key":"7114_CR18","doi-asserted-by":"publisher","first-page":"e24154","DOI":"10.7759\/cureus.24154","volume":"14","author":"B Mohammed","year":"2022","unstructured":"Mohammed B, Dweik A, Al-Jobory O, McMaster K. Elevated Procalcitonin Levels in a Patient With Diabetic Ketoacidosis in the Absence of Infection. Cureus. 2022;14(4):e24154. https:\/\/doi.org\/10.7759\/cureus.24154.","journal-title":"Cureus"},{"issue":"8","key":"7114_CR19","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.2169\/internalmedicine.5841-20","volume":"60","author":"S Fukunaga","year":"2021","unstructured":"Fukunaga S, Hoshino Y, Sonoda H, et al. A Remarkable Elevation in the Procalcitonin Levels Due to Diabetic Ketoacidosis in a Hemodialysis Patient. Intern Med. 2021;60(8):1231\u20135. https:\/\/doi.org\/10.2169\/internalmedicine.5841-20.","journal-title":"Intern Med"},{"issue":"10","key":"7114_CR20","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3928\/00904481-20140924-10","volume":"43","author":"MK Litao","year":"2014","unstructured":"Litao MK, Kamat D. Erythrocyte sedimentation rate and C-reactive protein: how best to use them in clinical practice. Pediatr Ann. 2014;43(10):417\u201320. https:\/\/doi.org\/10.3928\/00904481-20140924-10.","journal-title":"Pediatr Ann"},{"issue":"5","key":"7114_CR21","doi-asserted-by":"publisher","first-page":"e1609","DOI":"10.1210\/clinem\/dgae500","volume":"110","author":"MF Yousif","year":"2025","unstructured":"Yousif MF, Dolak KD, Adhikari S, White PC. Risk Factors for Adverse Outcomes in Children With Diabetic Ketoacidosis. J Clin Endocrinol Metab. 2025;110(5):e1609\u201318. https:\/\/doi.org\/10.1210\/clinem\/dgae500.","journal-title":"J Clin Endocrinol Metab"},{"key":"7114_CR22","doi-asserted-by":"publisher","unstructured":"Ahmad R, Narwaria M, Singh A, Kumar S, Haque M. Detecting Diabetic Ketoacidosis with Infection: Combating a Life-Threatening Emergency with Practical Diagnostic Tools. Diagnostics (Basel). 2023;13(14). https:\/\/doi.org\/10.3390\/diagnostics13142441.","DOI":"10.3390\/diagnostics13142441"},{"issue":"23\u201324","key":"7114_CR23","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/j.cca.2010.08.004","volume":"411","author":"S Kruger","year":"2010","unstructured":"Kruger S, Ewig S, Kunde J, et al. Assessment of inflammatory markers in patients with community-acquired pneumonia\u2013influence of antimicrobial pre-treatment: results from the German competence network CAPNETZ. Clin Chim Acta. 2010;411(23\u201324):1929\u201334. https:\/\/doi.org\/10.1016\/j.cca.2010.08.004.","journal-title":"Clin Chim Acta"},{"issue":"4","key":"7114_CR24","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1378\/chest.128.4.2223","volume":"128","author":"M Masia","year":"2005","unstructured":"Masia M, Gutierrez F, Shum C, et al. Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index. Chest. 2005;128(4):2223\u20139. https:\/\/doi.org\/10.1378\/chest.128.4.2223.","journal-title":"Chest"},{"issue":"7","key":"7114_CR25","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1086\/339198","volume":"34","author":"P Hausfater","year":"2002","unstructured":"Hausfater P, Garric S, Ayed SB, Rosenheim M, Bernard M, Riou B. Usefulness of procalcitonin as a marker of systemic infection in emergency department patients: a prospective study. Clin Infect Dis. 2002;34(7):895\u2013901. https:\/\/doi.org\/10.1086\/339198.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"7114_CR26","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1097\/PEC.0000000000002934","volume":"39","author":"O Hamtzany","year":"2023","unstructured":"Hamtzany O, Weiser G, Heiman E, Avnon-Ziv C, Auerbauch A, Levy-Khademi F. Leukocytosis and C-Reactive Protein Levels as Indicators of Infection in Children With Diabetic Ketoacidosis. Pediatr Emerg Care. 2023;39(11):828\u201331. https:\/\/doi.org\/10.1097\/PEC.0000000000002934.","journal-title":"Pediatr Emerg Care"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-026-07114-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-07114-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-07114-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:39:19Z","timestamp":1787791159000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12887-026-07114-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7114"],"URL":"https:\/\/doi.org\/10.1186\/s12887-026-07114-9","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"3 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Board (IRB) of UT Southwestern Medical Center. It was considered an exempt study (need for consent to participate was waived) by the IRB (Institutional Review Board of UT Southwestern Medical Center) due to the retrospective and de-identified nature of the data. Thus, this study adhered to the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"799"}}